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Abstract: Conducted electrical weapons (CEWs) have potential as effective alternatives 
to chemical restraint for short-term nonroutine capture and handling of wildlife. To assess 
immediate and delayed physiologic effects of exposure to a CEW, we assigned 15 captive 
reindeer (Rangifer tarandus tarandus) to 1 of 3 treatment groups: immobilized with carfentanil 
and xylazine (CX), 10-second exposure to a CEW, or exposure to the CEW while immobilized 
with CX (CEW+CX). Blood samples were collected pre-treatment, immediately post-
intervention, 10 minutes, 20 minutes, 4 hours, and 24 hours post-intervention. Physiologic 
effects were evaluated by analysis of blood, clinical observation for signs of physiologic 
compromise, and vital signs. Parameters that changed significantly (P < 0.05) post-
exposure (lactate, glucose, rectal temperature, blood oxygen, cardiac troponin I, cortisol, 
and catecholamines) were not significantly different from baseline values within 24 hours. 
Cortisol, glucose, and peak rectal temperature were lower in CEW-exposed individuals, while 
lactate, oxygen, and catecholamines were higher than for the CX-exposed individuals. The 
catecholamine response observed in the CEW-only group paralleled the response in the 
CEW+CX group. No long-term health effects were detected from either restraint method. Use 
of a CEW does not appear to increase the risk of capture myopathy. 
Key words: conducted electrical weapon, physiological response, Rangifer tarandus tarandus, 
reindeer, TASER®
Effective wildlife management includes 
efficient and safe methods for short-term restraint 
to reduce stress on animals while facilitating 
actions such as sample collection, restraint, 
handling for the purpose of relocation, or release 
from snares or entanglements. Chemical restraint 
is frequently used but may not be appropriate in 
all situations, such as when there is a risk to the 
public from misdirected projectiles, restrictions 
on use of projectors considered firearms, or from 
exposure to controlled substances (e.g., opioids) 
from darts or drug residue in meat salvaged 
for consumption. Additionally, many of the 
drugs used for chemical restraint are controlled 
substances, and trained personnel that can 
legally administer them are not always available. 
Darting and chemical restraint also have 
inherent risks to wildlife including injury and 
capture mortality (Kock et al. 1987). Conducted 
electrical weapons (CEWs; Figure 1) are being 
used as a nonlethal alternative for short-term 
(<1 min) restraint or hazing (Lewis et al. 2011). 
Interest is high among wildlife agencies in 
the efficacy of this tool. Preliminary research 
was undertaken by Alaska Department of Fish 
and Game Division of Wildlife Conservation 
at the Kenai Moose Research Center (Sterling, 
Alaska, USA) to evaluate CEW effects on 
moose (Alces alces; K. B. Beckmen, Alaska 
Department of Fish and Game, unpublished 
data), and those results were considered when 
designing this study as well as for developing 
a standard operating procedure for CEW use 
by the Alaska Department of Fish and Game 
(2010). Since then, Alaska Department of Fish 
and Game Division of Wildlife Conservation 
personnel have used CEWs for human safety 
while temporarily restraining wildlife, such as 
moose, to remove them from entanglements 
(Lewis et al. 2011). For example, as an alternative 
to killing a cow moose, a CEW has been used 
to protect personnel from an aggressively 
protective cow in order to rescue her calf that 
had gotten trapped in an open pit (Lewis et 
al. 2011). Additionally, a CEW has been used 
for hazing and aversive conditioning in >400 
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bears (Ursus spp.) between 2010 and 2017 at 
Port Armstrong, a remote fish hatchery on 
Baranof Island near Sitka, Alaska, USA and at 
other locations around Alaska. Application of 
CEWs to bears led to greater human avoidance 
behavior and decreased returns to the human-
occupied areas of the fish hatchery compared 
to the use of other standard hazing methods 
(P. Mooney, Alaska Department of Fish and 
Game, unpublished data). 
Conducted electrical weapons have wide-
spread use by law enforcement agencies for the 
restraint of humans. In humans, CEWs have 
been found to reduce the rate and severity of 
injuries in both suspects and officers (Smith 
et al. 2007, Bozeman et al. 2009). However, 
there are still safety concerns, including their 
contribution to arrest-related deaths (Bozeman 
et al. 2009, Jauchem 2015). Many of the concerns, 
especially potentially fatal cardiac effects (such 
as ventricular fibrillation) and acidosis (from 
increased lactate), although not reported in 
humans, are based on animal model studies. 
These animal studies have been mostly done 
in pigs (Sus sp.; Walter et al. 2008, Jauchem et 
al. 2009, Jauchem 2015), where prolonged or 
repeated discharges and location of the probes 
(such as transcardiac positioning or direct 
chest exposures) may be factors. In humans, 
physiological changes (including measures of 
stress, acidosis, and cardiovascular disruption) 
from exposure to CEWs have been no greater 
than those seen with other law enforcement 
nonlethal restraint methods (Ho et al. 2008, 
Dawes et al. 2009, Ho et al. 2009a, Ho et al. 
2009b, Ho et al. 2010). 
The American Veterinary Medical Association 
does not currently recommend the use of electro-
immobilization, such as with a CEW, for routine 
capture or restraint of animals (AVMA 2008, 
AVMA 2010). The concern with their use is the 
potential for distress and physical discomfort 
to an animal. Their use has been considered 
potentially appropriate in emergency or life-
threatening situations when dealing with an 
aggressive or dangerous animal. It is not the 
intent of this paper to recommend the use of 
CEWs for routine capture. The goals of this 
study are to better understand the effects of 
CEWs on animals to evaluate their potential use 
in management situations when other methods 
(such as chemical immobilization) are not 
available or practical.
Because of the concern for capture myopathy 
(or exertional rhabdomyolysis) in wildlife, it 
is critical to ascertain that use of a CEW does 
not add more stress than is already associated 
with capture and handling. Capture myopathy 
is a syndrome that leads to fatality and is seen 
in situations after prolonged or severe stress or 
exertion in animals. It is characterized by muscle 
(skeletal and cardiac) necrosis and renal failure. 
Acidosis (low blood pH, often due to increased 
lactic acid) and hyperthermia may exacerbate 
the condition (Williams and Thorne 1996). 
The goal of this study was to assess the 
immediate and delayed physiologic effects of 
exposure to a CEW and compare them to the 
effects of chemical restraint using carfentanil 
and xylazine (CX), the standard drug 
combination for wildlife capture and handling 
in the state of Alaska. Readily available captive 
reindeer (Rangifer tarandus tarandus) were 
used as a model for barren-ground caribou (R. 
tarandus granti) in this study. We hypothesized 
that the physiological effects of a CEW would 
not be significantly different than chemical 
restraint, and thus, would not pose a greater 
risk of capture myopathy.
Methods
In June 2014, 15 adult female reindeer housed 
at the Robert G. White Large Animal Research 
Station (University of Alaska Fairbanks 
Institute of Arctic Biology, Fairbanks, Alaska, 
USA) and habituated to physical restraint 
and blood collection were assigned to 1 of 3 
treatment groups (n = 5 for each treatment): 
Figure 1. TASER X2 device (TASER International, 
Scottsdale, Arizona, USA). Axon/TASER does not 
endorse the use of their products for wildlife usage.
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immobilized (hand injection IM) with CX (0.03 
mg/kg carfentanil and 0.3 mg/kg xylazine), a 
10-second exposure to a CEW, or a 10-second 
exposure to the CEW while immobilized with 
CX (CEW+CX). 
For CEW interventions, a TASER X3W® 
wildlife-specific handheld conducted electrical 
weapon (TASER International, Scottsdale, 
Arizona, USA) was used (large animal setting). 
The device has an open circuit arcing voltage of 
50,000 V to achieve an arc to overcome resistance 
to air, fur, and hide and complete a circuit 
between the 2 wired probes through which the 
charge is delivered. When a circuit is complete, 
the voltage drops to approximately 1,200 V and 
the device delivers pulsed electricity consisting 
of 85–130 microcoulombs of charge per pulse 
at a pulse rate of 29 pulses per second (0.0035 
amperes). 
Pre-treatment (T0) blood samples were 
collected from each individual while halter 
tied. Animals were then exercised for 5 minutes 
by running them within the corridors between 
pens to simulate a pre-darting excitement, then 
brought into a chute for treatment. Subsequent 
blood samples were collected at the following 
time points: immediately (TC), 10 minutes (T1), 
20 minutes (T2), 4 hours (T3), and 24 hours 
(T4) post-intervention. For the immobilized 
individuals, drugs were injected, and anesthesia 
was induced (2–4 min) and maintained. After 
10 minutes post-injection, naltrexone (100 mg 
per mg of carfentanil given) and atipamazole 
(1 mg per 10 mg of xylazine given) were 
administered intravenously to antagonize the 
effects. Recovery to standing occurred in 2–4 
minutes. The TC for the individuals exposed to 
the CEW was immediately after the device was 
turned off; for the CX group, it was 10 minutes 
after the drugs were administered (just before 
antagonists were given). Behavior and vital 
signs were monitored throughout exposure 
and through recovery. Rectal temperature 
was measured with a clinical digital rectal 
thermometer.
Venous blood (from the jugular vein) was 
collected in lithium heparin (6 ml Vacutainer, 
Becton, Dickinson and Co, Franklin Lakes, New 
Jersey, USA) and serum separator evacuated 
tubes (8.5 ml Vacutainer, Becton, Dickinson 
and Co, Franklin Lakes, New Jersey, USA). 
Immediately after sampling, a subset of whole 
blood was tested using point of care devices. 
EPOC (Heska, Loveland, Colorado, USA) was 
used to determine pH, blood carbon dioxide 
(pCO2), blood oxygen (pO2), sodium (Na+), 
potassium (K+), chloride (Cl-), ionized calcium 
(Ca++), creatinine, glucose, and hematocrit at 
T0, T1, T2, and T3. Lactate Pro Analyzer (Arkray 
Global Business, Kyoto, Japan) was used to 
measure blood lactate at all 6 time points. 
Samples were centrifuged for 10 minutes 
at 1500 G (Clay Adams Triac centrifuge, 
Becton, Dickinson and Co, Franklin Lakes, 
NJ, USA). Serum and plasma were flash 
frozen in liquid nitrogen, then stored at –80°C 
until analyzed. The T0 and T3 serum were 
sent to the University of Alaska Fairbanks 
Animal Resources Center (Fairbanks, Alaska, 
USA) for chemistry analysis on an Element 
DC Veterinary Chemistry Analyzer (Heska, 
Loveland, Colorado, USA) using test slides for 
albumin, alkaline phosphatase (ALP), alanine 
transferase (ALT), blood urea nitrogen (BUN), 
total calcium, creatine kinase (CK), creatinine, 
cholesterol, gamma-glutamyl transferase (GGT), 
globulin, glucose, phosphorus, total bilirubin, 
and total protein. Additional serum samples 
(from T0, T1, T2, T3, and T4) were sent to 
Texas A&M Veterinary Medical Diagnostic 
Laboratory (College Station, Texas, USA) and 
tested for cardiac troponin I (cTnI) using a 
cardiac troponin I high sensitivity assay on 
an ADVIA Centaur CP Ultra-TnI (Siemans 
Healthcare, Tarrytown, New York, USA) and 
serum cortisol using a solid phase, competitive 
chemiluminescent enzyme immunoassay. 
Plasma (from T0, TC, and T3) was analyzed at Ani 
Lytics Incorporated (Gaithersburg, Maryland, 
USA) for catecholamines (epinephrine and 
norepinephrine) using a radio-immunoassay 
(RIA) with an extraction/acylation prior to 
assay. The reagents were obtained from ALPCO 
(Salem, New Hampshire, USA).
Data analysis
Mean and SD were calculated for all 
parameters. Additionally, the change from 
baseline (results from T3 minus results from 
T0) was calculated for blood chemistry results. 
The T3 laboratory chemistry analysis results 
for 1 individual (in the CEW+CX group) were 
outside of the expected physiologic range 
for most parameters. Comparing the results 
163Conducted electrical weapons • Lieske et al.
for glucose analyzed using the point of care 
device (EPOC) to the glucose results from 
the standard, benchtop laboratory chemistry 
analyzer, it appears there was an error with the 
laboratory results for that sample. There was 
no difference in the significance of the results 
whether the individual was retained or omitted 
from the analysis. When reporting means and 
ranges, the individual was omitted.
Glucose (serum chemistry and EPOC) and 
lactate (EPOC and Lactate Pro) results were 
found to be consistent between the different 
testing methods (glucose, r2 = 0.90 for all time 
points; lactate, r2 = 0.95 for lactate values <8 
mmol/L and r2 = 0.75 for values >8 mmol/L), 
so multiple comparison analyses were done 
using results from the method with the most 
data points (EPOC for glucose, Lactate Pro for 
lactate).
Differences among groups were determined 
using the Kruskal-Wallis nonparametric analysis 
blocked by treatment group and sampling time. 
For analyses where the global test was significant, 
pairwise comparisons were calculated using the 
Conover-Inman method. For all comparisons, P 
< 0.05 was considered significant. Analyses were 
done using Stats Direct (version 2.8.0, StatsDirect 
Ltd., England 2013).
Results
For all comparisons, the results at T0 
(baseline) did not vary significantly among 
treatment groups.
Within each treatment group, results at T3 (4 
hours post-intervention) were within an SD of 
the results at T0 for serum chemistry parameters 
Figure 2. Mean ± SD for parameters to evaluate stress in captive reindeer (Rangifer tarandus tarandus) 
whole blood (glucose), serum (cortisol), and plasma (catecholamines: norepinephrine and epinephrine) 
collected at baseline (T0), immediately post-exposure (TC), 10 min (T1), 20 min (T2), 4 hours (T3), and 
24 hours (T4) post-exposure to a 10-sec exposure to a conducted electrical weapon (CEW), immobiliza-
tion with carfentanil/xylazine (CX), or to the CEW while immobilized with CX (CEW+CX). Open points (Δ = 
CEW, ○ = CX, □ = CEW+CX) indicate values that differed significantly (P < 0.05) from T0 for that treat-
ment. Points with different capital letters indicate treatments that differed significantly from the other treat-
ments at that time point. Exposure occurred June 2014 in Fairbanks, Alaska, USA.
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with the exception of glucose and CK. For 
all treatment groups, CK was increased at T3 
compared to T0 (P = 0.0016); however, there 
was no significant difference among treatment 
groups at either time point. The range that CK 
increased was wide for all groups (339–9725 
U/L for CX, 365–2543 U/L for CEW, 418–8144 
U/L for CEW+CX).
Blood glucose (Figure 2) increased at T1 and 
T2 for all groups (and was still significantly 
elevated at T3 for the CX group). The increase 
in glucose was greater in the CX-treated group 
than the CEW group at T1 (P = 0.0017), T2 
(P = 0.0019), and T3 (P = 0.003), although 
results were not significantly higher than for 
the CEW+CX group. Glucose in the CEW+CX 
group was higher than the CEW group at T1 
(P = 0.0038) and T2 (P = 0.0048). For 1 individual 
in the CX group, blood glucose was measured 
at 24 hours post-exposure and had returned to 
baseline value (data not shown).
Cortisol (Figure 2) increased significantly 
from T0 within all treatment groups, peaking 
at T2 and decreasing to baseline by T3. The CX 
individuals had higher cortisol values at both 
T1 (P = 0.494) and T2 (P = 0.0375) than for the 
CEW individuals. The CEW+CX group did not 
vary significantly from either the CX or the 
CEW-treated groups.
Both epinephrine and norepinephrine peaked 
immediately after exposure to treatment for 
the CEW and CEW+CX groups (Figure 2). The 
values at TC were significantly higher for CEW 
and CEW+CX than for CX. Catecholamine 
levels decreased to baseline levels by T3. 
There was no significant difference between 
CEW and CEW+CX treatments at any time 
point. Within treatment groups, epinephrine 
decreased at TC compared to T0 or T3 for the 
CX group (P = 0.0123); however, there was no 
significant difference across time points for 
norepinephrine.
Significant differences in hematocrit (P = 
0.0066), pO2 (P = 0.0016), pCO2 (P = 0.0123), 
and glucose (P < 0.0001) were found for whole 
blood test using EPOC. Details of multiple 
comparisons for significant differences 
are further detailed below. No significant 
differences in treatment or time point results for 
pH, creatinine, Ca++, K+, or Na+ were found.
Hematocrit at T2 (37% ± 3.7) was lower 
compared to T0 (42% ± 3.5) for the CX-treated 
group (P = 0.034). For the CEW+CX group, 
hematocrit at T2 (39% ± 3.2; P = 0.0316) and T3 
(39% ± 2.1; P = 0.0394) were lower than at T0 
(43% ± 3.6). Although the hematocrit for the 
CEW group did not vary significantly across 
time points (P = 0.1318), it was higher than in 
either CX or CEW+CX at T1 (P < 0.0001 and P 
= 0.0265), T2 (P = 0.0011 and P = 0.0084), and 
higher than the hematocrit for CEW+CX at T3 
(P = 0.019).
Venous oxygen (Figure 3) was lower in the 
CX and CEW+CX groups at T1 (P < 0.0001 and 
P = 0.0018) and T2 (P < 0.0001 and P = 0.0012) 
compared to the CEW group. At T2, pO2 was 
also lower in the CX group than the CEW+CX 
group (P = 0.0485). By T3, pO2 had returned 
to baseline levels for all treatment groups. 
Within treatment groups, pO2 did not vary 
significantly across time points for CEW+CX. 
However, the pO2 for the CX group was lower 
at T1 (P = 0.012) and T2 (P = 0014) than at T0. 
In the CEW group, pO2 was higher at T1 (P = 
0.016) and T2 (P = 0.007) than T0.
There was no significant difference in pCO2 
(Figure 3) when comparing treatment groups 
at each time point. However, pCO2 did vary 
significantly over time within treatment 
groups. For the CEW group, pCO2 was lower 
at T1 (P = 0.0057) and T2 (P = 0.0008) than at 
T0, and for the CEW+CX group, pCO2 was 
lower at T1 (P = 0.02) and T2 (P = 0.0136) than 
at T3. Additionally, 1 individual in the CX 
group had a much higher pCO2 at T1 than 
any other individual (pCO2 = 56.8 mm/Hg), 
although as a group the pCO2 values did not 
vary significantly.
Cardiac troponin I (Figure 3) increased from 
baseline at T3 in all groups, although this within-
group increase was only statistically significant 
for the CEW and CEW+CX groups (P < 0.0001 
for both). Levels of cTnI remained higher at 
T4 compared to T0 for CEW (P = 0.0085) and 
CEW+CX (P = 0.0005). When comparing results 
between treatments at each time point, cTnI 
for the CEW+CX group at T3 was greater than 
for the other 2 groups (P = 0.0165 compared 
to CX and P = 0.0313 compared to CEW). The 
between-group differences for CEW and CX 
groups were not significant at any time point. 
By T4 (24 hours post-exposure), cTnI had 
decreased toward baseline levels; there were no 
significant differences between groups at T4.
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Lactate (Figure 4) increased and was higher 
at TC, T1, and T2 (P < 0.0001) than at T0 for all 
treatment groups. The increase was similar (and 
not significantly different at each time point) in 
both the CEW and CEW+CX groups. Lactate at 
TC, T1, and T2 for the 2 groups treated with the 
CEW was higher than the lactate peak for the 
CX-only group (P ranged from 0.006–0.0028 for 
Figure 3. Mean ± SD for captive reindeer (Rangi-
fer tarandus tarandus) respiratory (venous partial 
pressure of oxygen [pO2], carbon dioxide [pCO2]) 
and cardiac parameters (cardiac troponin I [cTnI]) 
in blood collected at baseline (T0),  10 min (T1), 20 
min (T2), 4 hours (T3), and 24 hours (T4) post- 
exposure to a 10-sec exposure to a conducted elec-
trical weapon (CEW), immobilization with carfent-
anil/xylazine (CX), or to the CEW while immobilized 
with CX (CEW+CX). Open points (Δ = CEW, ○ = CX, 
□ = CEW+CX) indicate values that differed signifi-
cantly (P < 0.05) from T0 for that treatment. Points 
with different capital letters indicate treatments that 
differed significantly from the other treatments at 
that time point. Exposure occurred June 2014 in 
Fairbanks, Alaska, USA.
Figure 4. Mean ± SD for captive reindeer (Rangifer 
tarandus tarandus) blood lactate, blood pH, and 
rectal temperature collected at baseline (T0), im-
mediately post-exposure (TC), 10 min (T1), 20 min 
(T2), 4 hours (T3), and 24 hours (T4) post- 
exposure to a 10-sec exposure to a conducted elec-
trical weapon (CEW), immobilization with carfent-
anil/xylazine (CX), or to the CEW while immobilized 
with CX (CEW+CX). Open points (Δ = CEW, ○ = CX, 
□ = CEW+CX) indicate values that differed signifi-
cantly (P < 0.05) from T0 for that treatment. Points 
with different capital letters indicate treatments that 
differed significantly from the other treatments at 
that time point. Exposure occurred June 2014 in 
Fairbanks, Alaska, USA.
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CEW compared to CX, and from 0.0094–0.0153 
for the CEW+CX comparisons). For all treatment 
groups, lactate returned to baseline values by 
T3. Although there was a slight decrease in pH 
at T1 for the CEW and CEW+CX groups, the 
change was not significant (P = 0.3537).
Rectal temperature (Figure 4) increased (P < 
0.001) in all groups after exposure to treatment 
(TC) and remained elevated through T2. The 
increase was greatest for the CX treatment 
groups. Temperatures in the CX group were 
elevated compared to the CEW group at TC 
(P = 0.0481), T2 (P = 0.0085), and approached 
significance at T1 (P = 0.0576). The CEW+CX 
temperatures were higher from those in 
the CEW group at T2 only (P = 0.0101). The 
CEW+CX and CX rectal temperatures did not 
vary significantly at any time point.
Discussion
For all treatment groups, the observed 
changes in lactate, glucose, rectal temperature, 
blood oxygen, cardiac troponin I, cortisol, and 
catecholamines were transient and returned to 
(or approached) baseline levels within 24 hours. 
No long-term (>24 hour) or life-threatening 
health effects were observed for either restraint 
method. All individuals were still alive 1 year 
later and had immediately returned to normal 
breeding function within the herd (J. Blake, 
University of Alaska Animal Research Center, 
personal communication).
Creatine kinase is often used as a measure 
of muscle stress or damage (both skeletal 
and cardiac). It can reversibly increase with 
muscle exertion from both handling as well 
as exercise. To interpret the results and 
determine if increases are normal physiological 
responses due to activity or indicative of 
a more severe myopathy, levels of other 
enzymes (which also might be affected) and 
other physiological parameters (like body 
temperature) are considered. The increase in 
CK between T0 and T3 was within an expected 
range due to the physical activity the animals 
underwent. Similar values have been reported 
in clover-trapped white-tailed deer (Odocoileus 
virginianus; Boesch et al. 2011), while much 
higher values for CK are reported in roe deer 
(Capreolus capreolus) captured with drive nets 
(Montane et al. 2003). The 2 individuals with 
the highest CK measured at T3, 9632 IU/L and 
8032 IU/L (from the CX and CEW+CX groups, 
respectively), were noted to have struggled 
while getting in the chute (CX individual) or had 
a stormy recovery from anesthesia (CEW+CX 
individual). These additional exertions can 
account for the observed elevations in CK. 
There was no evidence of capture myopathy 
triggered by any of the treatments in this 
study. The higher lactate (and lower pH, 
although it was not statistically significant) 
seen in the CEW-treated groups are consistent 
with the effects of muscle contraction due to 
the electronic stimulus. Similar lactate levels 
have been reported in clover-trapped white-
tailed deer (Boesch et al. 2011), darted moose 
(Evans et al. 2012), and in humans after intense 
physical activity (Ho et al. 2009b). The greater 
increase in rectal temperature in the CX-treated 
individuals is consistent with the impaired 
thermoregulation caused by the use of opioids 
(carfentanil in this case) and especially alpha-2 
adrenergic agonists (xylazine in this case). The 
observed increases in temperature and lactate 
(and decrease in pH) resolved within 24 hours. 
No evidence of renal dysfunction (assessed by 
BUN and creatinine) was found. Additionally, 
all individuals survived and continued to 
behave normally after the study. 
In addition to impaired thermoregulation, the 
use of chemical immobilizing agents has been 
associated with impaired cardiopulmonary 
function, including respiratory depression, 
hypoxemia, and decreased hematocrit 
(potentially a result of sequestration of 
erythrocytes in the spleen or vasodilation due 
to xylazine). The decrease in venous pO2 and 
hematocrit observed in the groups treated with 
CX is consistent with this. Cardiopulmonary 
effects in these individuals resolved after 
recovery (by 4 hours post-exposure). The 
decrease in blood oxygen observed with 
chemical restraint was not present in the 
CEW-exposed individuals. The increase in 
pO2 seen in the CEW only treated group is 
likely due to an increased respiratory rate 
observed immediately upon release of the 
electrical stimulus. The decreased pCO2 found 
in the CEW-exposed group is consistent with 
hyperventilation.
Cardiac troponin I is used as a measure of 
damage to cardiac muscle. The majority of 
cTnI is found within the cardiac muscle and is 
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released when the muscle undergoes damage 
(e.g., myocardial necrosis). In several species, 
myocardial necrosis (including damage caused 
by acute coronary syndrome) is characterized 
by cTnI levels increasing within 4 hours of 
onset of signs, peaking 24–36 hours later, and 
decreasing over the course of days to weeks 
(Cummins and Cummins 1987, Varga et al. 
2009, Agewall et al. 2011). However, it has been 
hypothesized that transient (cTnI levels return 
to baseline within 24 hours) mild increases 
may be due to the cytosolic component rather 
than damage leading to necrosis. Between 3% 
and 8% of cTnI is unbound in the cytoplasm. 
Mild transient increases have been reported 
after exercise in human, equine, and canine 
endurance runners (Durando et al. 2006, 
McKenzie et al. 2007, Nostell and Haggstrom 
2008, Gresslien and Agewall 2016) and may 
be related to a reversible ischemic event or 
a mismatch in the supply and demand for 
oxygen (White 2011). Although the mechanism 
is not fully understood, it is believed to 
be physiological rather than pathological 
(Gresslien and Agewall 2016).
Although cTnI was detected and increased 
levels were found in some individuals 
(especially for the CEW+CX group), the highest 
amount detected (0.35 ng/mL) was well below 
the levels reported by Varga et al. (2009) as 
being associated with myocardial necrosis 
(using the same assay) in cattle (Bos taurus; 
1.04 ng/ml). Additionally, the slight increases 
in our study animals were transient (returning 
to baseline within 24 hours), similar to the 
exercise-related changes described in other 
species (Durando et al. 2006, McKenzie et al. 
2007, Gresslien and Agewall 2016). Thus, the 
detected cTnI may be cytosolic cTnI rather 
than an indication of irreversible damage to 
cardiac muscle. The CEW+CX group may have 
been affected the most because of the increased 
demand for oxygen from the contracting 
muscles in response to the CEW coupled 
with the decreased heart and breathing rates 
caused by the drugs (oxygen supply/demand 
mismatch). The significance of the difference in 
the CEW group (both for T3 and T4) is likely 
due to the limitations of the nonparametric 
statistical methodology used (for which ranks 
of the measured results are used). The lack of 
cTnI detected at T0 in any individuals (unlike 
for the other 2 treatment groups) had a strong 
influence on the comparison of rankings.
Glucose, catecholamines (such as norepine-
phrine and its metabolite, epinephrine), and 
cortisol can be used to assess stress in an 
individual. Norepinephrine and epinephrine 
are part of the sympathetic nervous system 
acute response to stress, while cortisol is 
associated with the chronic response of the 
hypothalamic-pituitary-adrenocortical (HPA) 
axis. Glucose is released as a response to 
increased levels of cortisol and catecholamines. 
The immediate catecholamine response 
observed after exposure to the CEW, even 
in the group that was also treated with CX, 
is consistent with a physiological response, 
although a cognitive one (i.e., due to fear or 
pain) cannot be ruled out. The mean peak was 
similar to the catecholamine response in net-
gun captured bighorn sheep (Ovis canadensis; 
Martucci et al. 1992). In the CEW-exposed 
individuals, glucose levels were lower than, and 
cortisol levels were similar to levels measured 
in clover-trapped white-tailed deer (Boesch et 
al. 2011). Cortisol levels were also much lower 
than for drive-net captured roe deer (Montane 
et al. 2003) and similar to levels measured in 
captive reindeer exposed to light restraint or 
physical activity (Arnemo and Caulkett 2007). 
Exposure to a CEW does not appear to trigger 
a greater stress response than current physical 
restraint methods. Additionally, all measures 
of stress returned to (or approached) baseline 
within 4 hours, indicating no prolonged stress 
response. 
Evaluating relative stress with exposure 
to CX is complicated by the effects of the 
immobilizing drugs. The alpha-2 adrenergic 
agonist used, xylazine, blocks production of 
norepinephrine and epinephrine. This results 
in respiratory depression, hypotension, and 
bradycardia (Sinclair 2003). Additionally, 
xylazine decreases insulin release from the 
pancreas and increases glucose production 
from the liver (gluconeogenesis), resulting in 
hyperglycemia (Fagerholm et al. 2011). Thus, 
the decreased pO2 and increased glucose 
seen in the immobilized individuals is likely 
due to xylazine. The inhibitory effect on 
norepinephrine is consistent with the lack of a 
catecholamine response seen in the CX group. 
Additionally, naltrexone is an opioid receptor 
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antagonist. It significantly increases cortisol 
levels due to blocking the central opioid 
receptors (which are inhibitory), resulting in 
an activation of the HPA axis. The cortisol 
and glucose levels observed in the CX group 
are similar to those reported in medetomidine 
(a more potent alpha-2 adrenergic agonist) 
exposed reindeer (Miller et al. 2013), and CX-
exposed muskoxen (Ovibos moschatus; Harms et 
al. 2012).
Management implications
Most chemical immobilants are delivered to 
free-ranging wildlife via remotely projected 
darts. Darting, especially with heavy weight 
rapid injection darts, entails risks of injury, such 
as dart trauma and infections, well beyond mere 
immobilization. These effects were mitigated in 
this study by hand injection of the drugs (Cattet 
et al. 2006). Use of CEWs removes the risk of the 
severe morbidity and mortality risks directly 
associated with darting and anesthesia. 
The risks of using either CEW or chemical 
immobilization methods need to be assessed 
in relation to the circumstances and necessity 
of restraint. Both CEWs and CX have some 
physiologic effects that may be considered 
beneficial over the other (e.g., better 
oxygenation, less thermoregulatory disruption, 
decreased risk of bradycardia and bradypnea 
with use of CEWs; decreased immediate stress 
response with use of chemical immobilants). 
Both have strengths and limitations as tools 
for effective management of wildlife. While CX 
allows for longer handling time for intervention 
and can be administered from a longer distance 
including from a helicopter, it has more 
rigorous training and legal requirements. 
The use of a CEW has a very short duration 
of immobilization (<1 min), and has a limited 
range (<11 m, dependent on cartridge design). 
The CEW use, however, is less expensive, more 
readily available, has decreased health risks 
for the public as well as personnel, does not 
expire (cartridges have a 5-year shelf life), and 
is insensitive to most environmental conditions 
(except extreme cold below -20°C and heat 
greater than 50°C). 
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